GEMMA Biotherapeutics’ Post

The Automation of Adeno-Associated Virus (AAV) Analytics Workflow Incorporating automation into AAV research and development, tremendous advantages have been realized, allowing scientists to expedite their work and achieve groundbreaking discoveries. If you want to learn more on how Bio-techne automated immunoassay platform can help you to achieve groundbreaking advancements in therapeutic interventions and advancements in AAV analytical tools dont forget to register for the upcoming webinar. The webinar will walk you through the tools and reagents to: - enhance efficiency - improved accuracy - scale-up capabilities - cost effectiveness, - accelerated innovation - improved reproducibility Join Bio-techne to revolutinize and redefine the future of gene therapy. https://lnkd.in/dHUCzvpf #aav #immunoassay #genetherapy #automatedsolutions

Ask me today how to get a low-cost pilot study with up to 15 mice to jumpstart your pre-clinical research! #preclinical #pharmacology #mice #humanizedmice #pilotstudy #IND

📣We are delighted to announce the completion of a global collaboration agreement with the Shanghai Model Organisms Center (SMOC). This five-year agreement extends the existing partnership and will provide unique immuno-oncology platforms and services from all Crown Bioscience facilities worldwide. This strategic alliance includes: ✅The purchase and supply of a broad range of genetically engineered mouse models, including thousands of knock-in and knock-out humanized models, ✅Genetically engineered cell line development services, ✅Custom development of GEMM models and MuPrime™ (our tumor homograft models) leveraging SMOC-engineered mice. Globally, Crown Bioscience research affiliates will benefit from uniform pricing, comprehensive IP protection, and licensing rights. This uniformity is accompanied by a shared commitment to research excellence, unrivaled quality standards, and scientific innovation. Read more about this agreement ➡️ https://hubs.la/Q02yp5vv0 #Bioscience #Biotech #ImmunoOncology #Innovation Shanghai Model Organisms Center, Inc.

Our very own Chief Scientific Officer, Dr. Michael Kelly, shares his expert perspective with BioSpace on the evolving landscape of Duchenne treatments and what data and decisions we can anticipate this year. Dive into the full article below. #DuchenneResearch #CureDuchenne #InnovationInCare #Duchenne #DuchenneMuscularDystrophy

As part of #AMD and #LowVisionAwarenessMonth, ikarovec has written a piece for BioScienceToday, sharing their ambition to help those losing their sight. Please check out the link below: https://lnkd.in/eZ6JkB2d #NRP #Genetherapy #sightloss

Check out this article authored by one of our oligonucleotide specialists. Please reach out to us with any questions you may have! We would love to help!

A fascinating panel discussion today on the use of #spatialbiology in drug discovery and development. Thank you Dana A M Mustafa for chairing and the experienced panel of Alain van Gool, Mischa Houtkamp, Roderick Beijersbergen and William McTavish for all your contributions Topics covered included: • The importance of spatial biology in drug discovery • Examples of the spatial techniques used in practice / laboratories • Targeted therapy and drug mechanism of action • Challenges in the field • Future directions #spatialbiologycongress Erasmus MC X-omics Genmab Lunaphore

🚀 Next in our technology spotlight series: miR-eCLIP! 🚀 miR-eCLIP provides direct mapping of miRNA-mRNA and siRNA-mRNA interactions, offering deep insights into the biology of miRNAs and the detection of siRNA off-targets. Why Choose miR-eCLIP? • Discover miRNA Biology: Determine exactly where and how miRNAs bind, revealing the entire network of miRNA activity. • Find siRNA Off-Targets: Locate off-target binding by siRNAs to improve drug design. • Design Better AMOs: Improve miRNA blockers by identifying the specific bases involved in binding Swipe below to see how miR-eCLIP can enhance your research and drug development programs and visit our website to learn more: https://lnkd.in/g4Rjyt8a #TechnologySpotlight #RNAresearch #miReCLIP #miRNA #siRNA #Eclipsebio

“Cryopreservation for Advanced Therapies” This is a great resource for the CGT community featuring Allison Hubel, PhD, Jason Acker and Sean Werner. Sample from the article: https://lnkd.in/dGdvAJ2X Question: What are the most pressing priorities when it comes to standardization in this field? Hubel : Standardization would be fantastic, but I do not know if the field is ready for it. I have been a part of developing standards over many decades, none of which were actually used by people! The field must be elevated before standardization can take place. People need to understand the scientific principles behind preservation, and they need to understand how those scientific principles get translated into a protocol that is used for preservation. Then, that end outcome can be done consistently and reproducibly. From what I have seen, the level of proficiency of people who are in the field actually doing preservation, is very, very low. Standardization will not be adopted and used until that proficiency is improved. Nice job Cell & Gene Therapy Insights!

Imagine translating the information from 11,000 protein measurements from 55ul in mouse pre-clinical samples to a human study, same reagents, same amazing high-plex coverage #somascan #precisionmedicine #preclinicalmodel